Sialorrhea in Parkinson’s Disease

Sialorrhea, or excessive saliva beyond the margin of the lip, is a common problem in many neurological diseases. Previously, sialorrhea has been underrecognized in Parkinson’s disease (PD) patients. Despite this, many patients rank sialorrhea as one of the most debilitating complaints of Parkinson’s...

Full description

Bibliographic Details
Published in:	Toxins
Main Authors:	Jonathan Isaacson, Sanskruti Patel, Yasar Torres-Yaghi, Fernando Pagán
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Subjects:	sialorrhea botulinum toxin Parkinson’s disease drooling Abobotulinumtoxin A Incobotulinumtoxin A
Online Access:	https://www.mdpi.com/2072-6651/12/11/691

Similar Items

Feasibility and structure of a state hospital botulinum neurotoxin clinic for clozapine-induced sialorrhea
by: Ai-Li W. Arias, et al.
Published: (2025-08-01)

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations
by: Wolfgang H. Jost, et al.
Published: (2023-12-01)

Treatment of sialorrhea in Parkinson’s disease
by: Sahil Mehta, et al.
Published: (2022-01-01)

Cost-Effectiveness of IncobotulinumtoxinA in the Treatment of Sialorrhea in Patients with Various Neurological Conditions
by: Koji Makino, et al.
Published: (2020-03-01)

Facial expression analysis to uncover the relationship between sialorrhea and hypomimia in Parkinson’s disease
by: Eline Serbée, et al.
Published: (2025-10-01)

Long-Term Safety and Efficacy of Repeated Cycles of RimabotulinumtoxinB in the Treatment of Chronic Sialorrhea: Results of the OPTIMYST Trial
by: Rajesh Pahwa, et al.
Published: (2025-06-01)

Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease
by: Bruno Bergmans, et al.
Published: (2023-01-01)

Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis
by: Steffen Berweck, et al.
Published: (2022-08-01)

Botulinum toxin in the treatment of sialorrhea
by: Svetel Marina, et al.
Published: (2009-01-01)

Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
by: Santamato A
Published: (2016-01-01)

Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation
by: Carolina Gorodetsky, et al.
Published: (2021-07-01)

Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis
by: Shang-An Hung, et al.
Published: (2021-11-01)

Tropicamide ophthalmic solution reduces clozapine-induced sialorrhea: a case report
by: Ozge Kilic, et al.
Published: (2017-10-01)

The Role of Speech Therapy in Sialorrhea Management and Quality of Life: A Retrospective Study
by: Sofia Eva Olsson, et al.
Published: (2025-02-01)

Drooling in Patients with Cerebral Palsy: The Effectiveness of Botulinum Toxin A Treatment
by: O. A. Klochkova, et al.
Published: (2015-11-01)

Real-World Observational Analysis of Clinical Characteristics and Treatment Patterns of Patients with Chronic Sialorrhea
by: Michael A. Hast, et al.
Published: (2024-08-01)

IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy
by: A. L. Kurenkov, et al.
Published: (2021-08-01)

Ultrasound-guided Botulinum Toxin Injection into the Salivary Glands for Treating Sialorrhea in a Case of Small-cell Lung Cancer
by: Murat Çabalar, et al.
Published: (2023-08-01)

Botulinum toxin in the treatment of sialorrhea in severe neurological patients with tracheotomy
by: Mengmeng Shao, et al.
Published: (2023-08-01)

The effectiveness of ultrasound‐guided injection of BTX‐A in the management of sialorrhea in neurogenic dysphagia patients
by: Zitong He, et al.
Published: (2023-12-01)

Bilateral submandibular duct relocation for chronic sialorrhea: a 15 years of experience in children with a neurological disorder
by: Turki Imen Mehri
Published: (2023-01-01)

The Effectiveness of Botulinum Toxin Type A Injections in the Management of Sialorrhea
by: Özgür Sürmelioğlu, et al.
Published: (2018-06-01)

A Double-Blind Randomized Controlled Trial Investigating the Most Efficacious Dose of Botulinum Toxin-A for Sialorrhea Treatment in Asian Adults with Neurological Diseases
by: Mazlina Mazlan, et al.
Published: (2015-09-01)

Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults
by: Wolfgang H. Jost, et al.
Published: (2023-05-01)

Outcomes of IncobotulinumtoxinA Injection on Myalgia and Arthralgia in Patients Undergoing Temporomandibular Joint Arthroscopy: A Randomized Controlled Trial
by: David Faustino Ângelo, et al.
Published: (2023-06-01)

Fragmented Facial Flushing: A Quiz
by: Alexis B. Lyons, et al.
Published: (2024-06-01)

Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice
by: Richard D. Zorowitz, et al.
Published: (2025-02-01)

Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal
by: Wolfgang H. Jost
Published: (2021-01-01)

Botulinum Toxin Treatment in Hereditary Spastic Paraplegia—A Comprehensive Review and Update
by: Bahman Jabbari, et al.
Published: (2025-10-01)

Budget Impact Analysis of Botulinum Toxin Type A for Patients with Severe Blepharospasm in Thailand
by: Hirunwiwatkul P, et al.
Published: (2025-10-01)

Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data
by: François Giuliano, et al.
Published: (2023-06-01)

Dealing With Clozapine-Induced Sialorrhea
by: J. Sá Couto, et al.
Published: (2022-06-01)

Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
by: Alberto Albanese, et al.
Published: (2023-05-01)

Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
by: Jörg Wissel, et al.
Published: (2021-12-01)

Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
by: Travis J.W. Hassell, et al.
Published: (2020-04-01)

Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies
by: Alberto Esquenazi, et al.
Published: (2020-09-01)

Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review
by: Hassan Galadari, et al.
Published: (2021-02-01)

Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?
by: Joely Kaufman-Janette, et al.
Published: (2021-07-01)

Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study
by: Mandar Jog, et al.
Published: (2020-12-01)

Botulinum Toxin, a Drug with Potential Interest for Dentists—An Introduction
by: Merete Bakke
Published: (2022-09-01)